Yeah, yeah, that’s the ticket

To say that athletics defines Joe Worlund may be a bit of a stretch. But to say that Worlund has defined much of what happens in the Athletic Complex may not be too far-fetched. Whether directing a fledgling intramural program, assuming a role on a 10-time University Athletic Association volleyball coaching staff of the year, […]

Oh baby!

Photo by Robert BostonPhysical therapy students in “Kinesiology II” try to guess how old Brodie Pratt is by his movements while he plays with his grandmother.

Researchers defeat tumor cells by inhibiting healthy cells

Mice with Tax-induced leukemia/lymphoma develop large tumors and many areas of bone destruction, as shown in this X-ray.Defeating cancerous tumors by attacking healthy cells seems like an unusual strategy, but researchers at the School of Medicine have shown the strategy to be effective against leukemia/lymphoma in mice. The research group found that inhibiting normal bone-maintenance cells called osteoclasts not only prevented the mice’s cancer from spreading to their bones, it also slowed the growth of tumors in the body’s soft tissues.

Scientists find receptor for molecule that helps synchronize fly’s internal clocks

WUSM scientists have identified a protein that helps keep internal “clocks” in sync.Scientists have identified a receptor protein that helps the fruit fly know when to start and shut down its day. Neuroscientists from the School of Medicine identified a receptor for pigment-dispersing factor (PDF) protein, which scientists previously recognized as a molecule that helps keep different internal “clocks” synchronized. Because these timekeeping processes have been highly conserved through evolution, what the scientists learn from flies and other organisms may help them better understand the same systems in humans.

Study eases concerns over mental side effects from potent AIDS drug

Sustiva is the brand name for efavirenz.The largest detailed, prospective clinical study of the mental side effects of a potent anti-AIDS drug, efavirenz, has revealed that the anxiety, dizziness, “funny feelings” and vivid dreams triggered by the drug fade away within a month, possibly clearing the way for more widespread use. Efavirenz is the first drug from its class that lasts long enough to be taken once a day, and that makes it a potentially valuable drug for AIDS treatment.
Older Stories